BRTX (BioRestorative Therapies) EPS (Basic): $-1.07 (TTM As of Mar. 2026)


BRTX BioRestorative Therapies Inc BRTX
51 GF Score
Price $0.39
GF Value $1.52
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is BioRestorative Therapies EPS (Basic)?

BioRestorative Therapies BRTX -2.69% 51 EPS (Basic) is $-1.07 as of Mar. 2026. GuruFocus rates BRTX with a GF Score™ of 51/100 and a GF Value™ of $1.52 (Possible Value Trap). The stock has 3 warning signs investors should review.

BioRestorative Therapies's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $-0.12. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.07.

BioRestorative Therapies's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.12. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.07.

BioRestorative Therapies's EPS without NRI for the three months ended in Mar. 2026 was $-0.19. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -1.33.

During the past 3 years, the average EPS without NRI Growth Rate was 30.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 39.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 65.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, BioRestorative Therapies's highest 3-Year average EPS without NRI Growth Rate was 89.60% per year. The lowest was 21.20% per year. And the median was 34.00% per year.

BioRestorative Therapies  (NAS:BRTX) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

BioRestorative Therapies EPS (Basic) Related Terms

BioRestorative Therapies EPS (Basic) Historical Data

* Premium members only.

The historical data trend for BioRestorative Therapies's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioRestorative Therapies EPS (Basic) Chart

BioRestorative Therapies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.30 -3.65 -2.47 -1.16 -1.58

BioRestorative Therapies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.64 -0.30 -0.33 -0.32 -0.12
BRTX
51GF Score
BioRestorative Therapies Inc BRTX
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioRestorative Therapies EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

BioRestorative Therapies's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-14.242-0)/8.993
=-1.58

BioRestorative Therapies's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-2.154-0)/17.728
=-0.12

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-1.07 mean?
BioRestorative Therapies (BRTX) has a EPS (Basic) of $-1.07 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on BioRestorative Therapies and its competitors.
Is BioRestorative Therapies' EPS (Basic) too high?
BioRestorative Therapies' current EPS (Basic) is $-1.07. Overall, BioRestorative Therapies has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioRestorative Therapies' EPS (Basic) compare to KPRX and INTS?
BioRestorative Therapies' EPS (Basic) of $-1.07 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on BioRestorative Therapies and its competitors. BioRestorative Therapies's current EPS (Basic) is $-1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioRestorative Therapies stock overvalued right now?
Based on GuruFocus' analysis, BioRestorative Therapies (BRTX) is currently considered Possible Value Trap. The stock's GF Value™ is $1.52, compared to a current price of $0.39 — trading 74.6% below its estimated fair value. The current EPS (Basic) is $-1.07. BioRestorative Therapies' overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For BioRestorative Therapies (BRTX), the current EPS (Basic) is $-1.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioRestorative Therapies (BRTX) Overvalued in 2026?

Based on GuruFocus' analysis, BioRestorative Therapies stock appears to be undervalued. The current stock price of $0.39 is trading 74.6% below its estimated GF Value™ of $1.52. GuruFocus considers BioRestorative Therapies to be Possible Value Trap.

Key valuation signals for BRTX:

  • EPS (Basic): $-1.07
  • GF Value™: $1.52 vs. price of $0.39 (74.6% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the BRTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioRestorative Therapies Business Description

Other Exchanges 9OF:Germany
Address 40 Marcus Drive, Suite One, Melville, NY, USA, 11747
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
51GF Score

Get the complete analysis for BRTX

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.39
Price
$1.52
GF Value